Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCitigroup Inc Regulatory News (13PH)

  • There is currently no data for 13PH

Form 8.3 - offeree

22 Jun 2021 16:22

RNS Number : 7520C
Citigroup Inc
22 June 2021
 

Ap19

 

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

Citigroup Inc.

Company dealt in

Willis Towers Watson plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

US$0.000304635 ordinary shares

Date of dealing

 21 June 2021

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

3,803,472 2.95%

538,568 0.42%

(2) Derivatives (other than options)

7,535 0.01%

36,368 0.03%

(3) Options and agreements to purchase/sell

 

Total

3,811,007 2.95%

574,936 0.45%

       

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

       

 

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD)

Purchase

26,701

 Highest 230.18 Lowest 227.43

Sale

3,941

Highest 230.18 Lowest 224.89

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit (USD)

TRS

Reducing Long Position

21,402

230.18

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

22 June 2021

Contact name

Damian Flanagan

Telephone number

+ 44 (0) 2890 409 676

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUUUVRAUUNUAR
Date   Source Headline
27th Apr 20266:09 pmRNSHolding(s) in Company
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
10th Mar 20263:48 pmRNSHolding(s) in Company
3rd Feb 20261:22 pmRNSHolding(s) in Company
14th Jan 202612:23 pmRNSForm 8.5 (EPT/NON-RI) - Rio Tinto plc (CBNA)
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
3rd Oct 20256:19 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
15th Sep 202512:00 pmRNSIQE plc: Holding(s) in Company
9th Sep 20253:30 pmRNSIQE plc: Holding(s) in Company
5th Sep 20254:00 pmRNSIQE plc: Holding(s) in Company
29th May 20255:30 pmRNSHolding(s) in Company
11th Apr 20257:00 amRNSHolding(s) in Company
30th Jan 20259:45 amRNSForm 8.5 (EPT/NON-RI) - CBNA
6th Nov 20249:49 amRNSForm 8.5 (EPT/NON-RI) - (CBNA -NY)
26th Sep 202411:30 amRNSForm 8 (DD) - CBNA New York
26th Sep 202411:28 amRNSForm 8 (DD) - CBNA New York
26th Sep 202411:20 amRNSForm 8 (DD) - CBNA New York
27th Jun 202410:14 amRNSForm 8.5 (EPT/NON-RI) - CBNA New York
15th May 20244:58 pmRNS1st Quarter Results
24th Apr 20248:23 amRNSForm 8.5 (EPT/NON-RI)
23rd Apr 20248:51 amRNSForm 8.5 (EPT/NON-RI)
22nd Apr 20248:54 amRNSForm 8.5 (EPT/NON-RI)
5th Apr 202410:28 amRNSForm 8.5 (EPT/NON-RI)
8th Dec 202311:32 amRNSForm 8 (DD) - [offeree]-CBNA
23rd Jul 20214:10 pmRNSForm 8.3 - offeree
22nd Jul 20215:25 pmRNSForm 8.3 - offeree
21st Jul 20213:01 pmRNSForm 8.3 - offeree
20th Jul 20213:49 pmRNSForm 8.3 -offeree
19th Jul 20213:44 pmRNSForm 8.3 - offeree
16th Jul 20212:39 pmRNSForm 8.3 - offeree
15th Jul 20212:38 pmRNSForm 8.3 - offeree
14th Jul 20212:29 pmRNSForm 8.3 - offeree
13th Jul 20213:03 pmRNSForm 8.3 - offeree
12th Jul 20212:12 pmRNSForm 8.3 - offeree
9th Jul 20213:55 pmRNSForm 8.3 - offeree
8th Jul 20214:10 pmRNSForm 8.3 - offeree
7th Jul 20214:47 pmRNSForm 8.3 - offeree
5th Jul 20212:48 pmRNSForm 8.3 - offeree
2nd Jul 20212:38 pmRNSForm 8.3 - offeree
1st Jul 20212:54 pmRNSForm 8.3 - offeree
30th Jun 20212:29 pmRNSForm 8.3 - offeree
29th Jun 20213:09 pmRNSForm 8.3 - offeree
28th Jun 20211:53 pmRNSForm 8.3 - offeree
25th Jun 20213:04 pmRNSForm 8.3 - offeree

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.